Vitamin D Deficiency
Vitamin D is more than a secosteroid that regulates calcium and bone metabolism; in the skin it also acts as a hormone that shapes both innate and adaptive immunity. The epidermis is the only tissue in the body that can make vitamin D itself from its precursor 7-dehydrocholesterol under UVB light (290–315 nm) and also carries the enzyme 1-alpha-hydroxylase (CYP27B1) to convert it locally into its most biologically active form, 1,25(OH)2D3 (calcitriol).
Inside keratinocytes, Langerhans cells and skin T cells, calcitriol binds the nuclear vitamin D receptor (VDR), directly switching on production of antimicrobial peptides (AMPs) and damping down overactive inflammatory pathways. Vitamin D deficiency therefore weakens the skin's innate immune barrier, which can trigger flares of chronic inflammatory skin diseases such as atopic dermatitis, psoriasis and vitiligo, and raises the risk of secondary bacterial and fungal infection.
At Haute-Derma, we follow a standardized micronutrient assessment: measuring serum 25(OH)D and the degree of skin barrier impairment (TEWL), then combining optimized oral vitamin D3 with targeted narrowband UVB (NB-UVB) phototherapy.
Pathophysiology and Skin Immune Mechanisms
Disease Mechanisms and Disruption of VDR Signaling
- Reduced Production of Innate Antimicrobial Peptides (AMPs):
- Calcitriol bound to VDR directly activates the promoters of the genes for cathelicidin (LL-37) and human beta-defensin 2 (hBD-2) in keratinocytes.
- Vitamin D deficiency sharply lowers LL-37 levels, stripping the skin of its "natural antibiotic" and allowing Staphylococcus aureus to multiply and Candida to invade.
- T-Cell Imbalance and Overactive Inflammation:
- Normal VDR signaling restrains the differentiation of T-helper 1 (Th1) and Th17 cells while promoting regulatory T cells (Tregs).
- Without enough vitamin D, Th1/Th17 activity goes unchecked and floods the skin with inflammatory cytokines (IL-17, IL-22, TNF-alpha, IL-4), driving the abnormal keratinocyte proliferation of psoriasis and the allergic flares of atopic dermatitis.
- Weakened Epidermal Barrier Cohesion: Calcitriol regulates tight junction proteins such as claudins and occludin. Vitamin D deficiency loosens these junctions, increasing transepidermal water loss (TEWL) and letting allergens penetrate more deeply.
How Vitamin D Deficiency Affects Chronic Skin Diseases
Atopic Dermatitis (AD)
- The link: In people with AD, lower serum 25(OH)D levels go hand in hand with higher (more severe) SCORAD scores.
- Mechanism: Low vitamin D reduces LL-37, which contributes to colonization by S. aureus, found in up to 90% of people with AD. Staphylococcal exotoxins act as superantigens that set off severe eczema flares with scaling, weeping and intense itch.
Psoriasis Vulgaris
- The link: 60–80% or more of people with psoriasis have insufficient or severely deficient vitamin D levels.
- Mechanism: Without VDR signaling, keratinocytes lose the ability to stop dividing and mature normally, leading to hyperproliferation. Together with infiltrating Th17 cells, this produces the thick, red, silvery-scaled plaques of psoriasis.
Vitiligo
- The link: Low vitamin D levels make pigment cells (melanocytes) more vulnerable to cytotoxic damage.
- Mechanism: Calcitriol protects melanocytes from apoptosis caused by reactive oxygen species (ROS) and boosts tyrosinase activity. Vitamin D deficiency speeds up autoimmune destruction of melanocytes, so the depigmented patches spread.
Alopecia Areata (AA): VDR is essential for maintaining the hair follicle cycle. Vitamin D deficiency disrupts the growth phase (anagen) and encourages an autoimmune attack on the hair bulb, causing round, coin-shaped bald patches.
Diagnostic Workup at Haute-Derma
Haute-Derma offers in-depth biochemical testing and skin immune assessment:
- Serum Vitamin D Level (Gold Standard): Total 25(OH)D (D2 + D3) measured by chemiluminescence immunoassay (CLIA) or LC-MS/MS.
- Blood Chemistry: Total calcium, ionized calcium, phosphorus and parathyroid hormone (PTH) to assess bone metabolism.
Treatment and Vitamin D Optimization for Skin Disease
Our approach pairs evidence-based oral supplementation with targeted local therapies:
Oral Vitamin D3 Supplementation
- Loading phase (correcting the deficit) (when 25(OH)D < 20 ng/mL): Vitamin D3 (cholecalciferol) 50,000 IU once a week for 8 consecutive weeks.
- Maintenance phase:
- Take vitamin D3 1,000–2,000 IU/day (or 50,000 IU every 2–4 weeks) to keep 25(OH)D in the optimal range (30–50 ng/mL).
- Note: Vitamin D3 may be combined with vitamin K2 (MK-7) to help direct calcium into bone and reduce the risk of soft-tissue or skin calcification.
Topical Treatment and Phototherapy
- Topical Vitamin D Analogs (Calcipotriol / Tacalcitol): Calcipotriol 0.005%, alone or combined with betamethasone dipropionate, is applied to psoriasis plaques. It binds VDR in keratinocytes directly and normalizes their maturation without the skin thinning that corticosteroids can cause.
- Narrowband UVB Phototherapy (NB-UVB 311 nm): Sessions 2–3 times a week prompt keratinocytes to make their own vitamin D3 while suppressing inflammatory T cells in the dermis, giving good results in psoriasis, atopic dermatitis and vitiligo.
